1. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA‐B) genotype and allopurinol dosing: 2015 update. Issue 1 (16th July 2015) Authors: Saito, Y; Stamp, LK; Caudle, KE; Hershfield, MS; McDonagh, EM; Callaghan, JT; Tassaneeyakul, W; Mushiroda, T; Kamatani, N; Goldspiel, BR; Phillips, EJ; Klein, TE; Lee, MTM Journal: Clinical pharmacology & therapeutics Issue: Volume 99:Issue 1(2016:Jan.) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Implementation of a pharmacogenomics consult service to support the INGENIOUS trial. Issue 1 (31st March 2016) Authors: Eadon, MT; Desta, Z; Levy, KD; Decker, BS; Pierson, RC; Pratt, VM; Callaghan, JT; Rosenman, MB; Carpenter, JS; Holmes, AM; McDonald, CA; Benson, EA; Patil, AS; Vuppalanchi, R; Gufford, BT; Dave, N; Robarge, JD; Hyder, MA; Haas, DM; Kreutz, RP Journal: Clinical pharmacology & therapeutics Issue: Volume 100:Issue 1(2016:Jul.) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗